Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients

Acta Anaesthesiologica Scandinavica

Volumn 45, Issue 8, 2001, Pages 929-934

  Bugge, J F ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute renal failure; Continuous renal replacement therapy; Drug dosing; Hemodiafiltration; Hemofiltration; Pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; METRONIDAZOLE; VANCOMYCIN;

CREATININE CLEARANCE; CRITICAL ILLNESS; DOSE CALCULATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG MONITORING; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY;

CRITICAL ILLNESS; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 0034815124     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2001.450802.x     Document Type: Review

References (27)

1. Intradialytic renal hemodynamics. Potential consequences for the management of the patient with acute renal failure
2. Continuous versus intermittent renal replacement therapy in the intensive care unit
3. Pharmacokinetics in renal disease
4. Effect of free fatty acids on protein binding of antimicrobial agents
5. Impaired binding of drugs and endogenous ligands in renal disease
6. Endogenous accumulation products and serum protein binding in uremia
7. Phenytoin toxicity in a critically ill, hypoalbuminemic patient with normal serum drug concentrations
8. Drug administration in critically ill patients with acute renal failure
9. Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage
10. Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration
11. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system
12. Binding of antibiotics by dialysis membranes and its clinical relevance
13. Aminoglycoside binding to polyacrylonitrile hemofilter during continuous hemofiltration
14. The interaction of albumin and drugs with two hemofiltration membranes
15. A primer on continuous renal replacement therapy for critically ill patients
16. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates
17. Continuous arteriovenous hemofiltration and related therapies
18. CRRT efficiency and efficacy in relation to solute size
19. Drug dosing adjustments during continuous renal replacement therapies
20. Continuous arteriovenous hemodiafiltration: Predicting the clearance of drugs
21. Drug clearance by continuous haemodiafiltration (CAVHD). Analysis of sieving coefficients and mass transfer coefficients of diffusion
22. Management of drug dosing in continuous renal replacement therapy
23. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous hemofiltration
24. Pharmacokinetic studies in volunteers with renal impairment
25. Individualized drug dosage in patients treated with continuous hemofiltration
26. Aminoglycoside nephrotoxicity